Contact Us
 • 
Home
Search 

Clinical Trials > SAVER  

  • Information
  • Sites - Interested
SAVER   

Title

Sodium Valproate for Epigenetic Re-programming in Management of High Risk Oral Epithelial Dysplasia: a randomised, double blind, placebo controlled clinical trial with embedded mechanistic and feasibility studies.


Basic Trial Information

Phase Type Status Age Sponsor Protocol IDs
II Funded and in setup The University of Liverpool

Trial Start Date

Trial Not Open


Trial Coordinator

Binyam Tesfaye


Trial Coordinator Email Address

btesfaye@liverpool.ac.uk


Trial Coordinator Contact No

0151 795 7328



UK: SCOTLAND

  • Glasgow, Queen Elizabeth University Hospital (James McCaul)